Watson Pharmaceuticals is expected to bid as much as €5 billion ($6.6 billion) for the Swiss drug maker Actavis Group, in a deal that would create one of the world's largest generic drug manufacturers.
read more
Teva Pharmaceuticals Industries, the world’s largest maker of generic drugs, confirmed Friday it would buy Barr Pharmaceuticals of New Jersey for about $7.5 billion in cash and stock. Early reports of such a deal sent shares of Barr... Read Post
Generic drug maker Actavis is growing faster than the European sector, according to its chief executive and is set to contribute at least €2 billion ($2.6 billion) to this year's sales of U.S. based Watson Pharmaceuticals, which bou... Read Post
Watson Pharmaceuticals is expected to offer 4.5 billion euros ($5.9 billion) for Swiss drug maker Actavis Group on Wednesday, in a deal that would create one of the world's largest generic drug manufacturers. Read Post